Differential systemic arterial and venous actions and consequent cardiac effects of vasodilator drugs.
D000804:Angiotensin II / Q000037:antagonists & inhibitors; D001158:Arteries / Q000187:drug effects*; D001775:Blood Circulation / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004280:Dobutamine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006801:Humans; D006830:Hydralazine / Q000494:pharmacology; D008914:Minoxidil / Q000494:pharmacology; D005996:Nitroglycerin / Q000494:pharmacology; D009599:Nitroprusside / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011224:Prazosin / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*; D014680:Veins / Q000187:drug effects*
D004983:Ethanolamines; D014665:Vasodilator Agents; D000804:Angiotensin II; D009599:Nitroprusside; D006830:Hydralazine; D004280:Dobutamine; D008914:Minoxidil; D005996:Nitroglycerin; C009118:pirbuterol; D004298:Dopamine; D011224:Prazosin; D010646:Phentolamine